seqWell

Biotechnology ResearchMassachusetts, United States11-50 Employees

seqWell develops scalable genomics technologies that streamline library preparation workflows for sequencing projects. Central to its approach is TnX, a transposase-based technology designed to increase the scalability and performance of tagmentation. Its library prep kits and fragmentation workflows support rapid scaling of both short- and long-read sequencing initiatives.

Headquartered in Beverly, Massachusetts, seqWell operates in the biotechnology research space, supplying genomic library construction and multiplexing workflow solutions to researchers and sequencing facilities. Its offerings address the needs of scientists undertaking high-throughput sequencing by simplifying library preparation and enabling scalable workflows across diverse applications. In February 2026, seqWell announced the launch of MosaiX, a library prep kit designed for high-throughput NGS applications, including human whole-genome sequencing, large plant and animal genomics, and targeted panels.

Sign up for free to view info

Email Format Employee directory